|
Market Closed -
Swiss Exchange
16:30:29 23/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 117.60 CHF | +0.98% |
|
+2.91% | +7.30% |
| 08:44am | Twenty years of Europe's stock market told through ten stocks |  |
| 09-22 | Celldex shares slip as safety concerns cloud skin drug trial win | RE |
| Market Cap | 270B 237B 222B 203B 380B 25,816B 383B 2,671B 1,035B 13,162B 1,012B 990B 42,675B | P/E 2026 * |
20x | P/E 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise Value | 301B 264B 248B 227B 424B 28,841B 428B 2,984B 1,157B 14,704B 1,131B 1,106B 47,675B | EV / Sales 2026 * |
5.21x | EV / Sales 2027 * | 4.84x |
| Free-Float |
91.66% | Yield 2026 * |
3.07% | Yield 2027 * | 3.2% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
CBOE
| 0QLR | Real-time | |
|
OTC Markets
| NVSEF | Delayed | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
Xetra
| NOT | Delayed | |
|
Xetra
| NOT | End-of-day quote | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
London S.E.
| 0QLR | Delayed | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Börse Stuttgart
| NOT | Delayed | |
|
Boerse Muenchen
| NOT | Real-time | |
|
CBOE
| Real-time | ||
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | +0.89% | ||
| 1 week | +2.91% | ||
| Current month | -4.59% | ||
| 1 month | -7.23% | ||
| 3 months | -4.72% | ||
| 6 months | +1.27% | ||
| Current year | +7.30% |
| 1 week | 114.66 |  | 118.8 |
| 1 month | 110.3 | | 132.68 |
| Current year | 107.68 | | 132.68 |
| 1 year | 96.8 | | 132.68 |
| 3 years | 81.1 | | 132.68 |
| 5 years | 72.84 | | 132.68 |
| 10 years | 65.09 | | 132.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 31/01/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 15/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 13/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 31/12/2014 |
| Director/Board Member | 69 | 31/12/2015 | |
Ton Büchner
BRD | Director/Board Member | 61 | 31/12/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/05/26 | Sell | -5,200 | 0.0003% | |||
| 04/05/26 | Sell | 6,800 | 0.0003% | |||
| 17/02/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | +2.91% | +20.59% | +27.14% | 270B | |
| -1.77% | +1.04% | +53.90% | +108.15% | 1,043B | |
| -0.51% | -0.05% | +51.29% | +66.70% | 649B | |
| -0.04% | +0.86% | +18.94% | +71.21% | 469B | |
| -0.25% | +0.19% | +36.95% | +45.54% | 355B | |
| -1.91% | +2.42% | +10.41% | +11.04% | 262B | |
| -0.87% | +8.18% | +41.96% | +52.57% | 222B | |
| -1.34% | +1.94% | +31.60% | +101.18% | 189B | |
| -2.53% | -7.47% | -32.63% | -60.41% | 175B | |
| +0.81% | +2.53% | +16.68% | -14.63% | 159B | |
| Average | -0.70% | +2.12% | +24.97% | +40.85% | 379.22B | |
| Weighted average by Cap. | -0.84% | +2.15% | +34.80% | +61.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.74B 50.68B 47.64B 43.55B 81.39B 5,531B 81.99B 572B 222B 2,820B 217B 212B 9,143B | 61.39B 53.89B 50.65B 46.31B 86.54B 5,881B 87.18B 608B 236B 2,998B 231B 226B 9,722B |
| Net income | 14.2B 12.46B 11.71B 10.71B 20.01B 1,360B 20.16B 141B 54.54B 693B 53.31B 52.14B 2,248B | 15.75B 13.83B 13B 11.88B 22.21B 1,509B 22.37B 156B 60.52B 769B 59.16B 57.86B 2,494B |
| Net Debt | 31.58B 27.72B 26.05B 23.82B 44.51B 3,025B 44.84B 313B 121B 1,542B 119B 116B 5,000B | 27.89B 24.47B 23.01B 21.03B 39.31B 2,671B 39.6B 276B 107B 1,362B 105B 102B 4,415B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/09/26 | CHF 117.60 | +0.98% | 3,261,410 |
| 22/09/26 | CHF 116.46 | +0.28% | 2,904,594 |
| 21/09/26 | CHF 116.14 | +0.90% | 2,020,945 |
| 18/09/26 | CHF 115.10 | -0.79% | 8,399,187 |
| 17/09/26 | CHF 116.02 | +1.52% | 2,407,734 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
